Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
NCT03757130
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
AMG 598
DRUG:
Placebo
DRUG:
Liraglutide
Sponsor
Amgen